7.20

3.23% -0.24

After Hours: 7.18 -0.02 -0.28%

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $7.20, with a volume of 4.40M. It is down -3.23% in the last 24 hours and up +31.15% over the past month. Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Previous Close:

$7.44

Open:

$7.5

24h Volume:

4.40M

Relative Volume:

0.83

Market Cap:

$2.58B

Revenue:

$9.68M

Net Income/Loss:

$-250.64M

P/E Ratio:

-5.1436

EPS:

-1.3998

Net Cash Flow:

$-89.83M

1W Performance:

+18.03%

1M Performance:

+31.15%

6M Performance:

+64.38%

1Y Performance:

+97.80%

1-Day Range:

$7.10

$7.50

1-Week Range:

$6.10

$7.50

52-Week Range:

$2.99

$7.50

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2026-08-04

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	7.20	2.66B	9.68M	-250.64M	-89.83M	-1.3998
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

Aug 21, 2026

Precigen (PGEN) officer targets $259,935 insider stock sale - Stock Titan

Aug 21, 2026

Precigen (NASDAQ:PGEN) Trading Down 3.6%Here's Why - MarketBeat

Aug 21, 2026

3 Growth Companies With High Insider Ownership And 55% Earnings Growth - simplywall.st

Aug 21, 2026

$Precigen (PGEN.US)$ keep it up! - Moomoo

Aug 21, 2026

Aug 20, 2026

Precigen (NASDAQ:PGEN) Hits New 12-Month HighTime to Buy? - MarketBeat

Aug 20, 2026

Precigen stock hits 52-week high at 7.33 USD By Investing.com - Investing.com Australia

Aug 20, 2026

Reasons Why Investors Should Consider Betting on PGEN Stock - TradingView

Aug 20, 2026

Aug 19, 2026

Precigen (PGEN) Stock: Ends Up by 6.30% at $7.17 in the Latest Session; Key Range: Support at $6.81 and Resistance at $7.53 Frame the Range under the Current SnapshotPut Spread Alert - vinanet.vn

Aug 19, 2026

Stock Traders Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat

Aug 19, 2026

Alpine Woods Capital Investors LLC Takes $1.31 Million Position in Precigen, Inc. $PGEN - MarketBeat

Aug 19, 2026

$Precigen (PGEN.US)$ DCA'd Up. Ready for the next leg higher - Moomoo

Aug 19, 2026

Aug 18, 2026

Precigen (PGEN) Price and Levels: Finishes 3.05% Higher at $6.75 in the Latest Session; $6.41 and $7.09 Define the Nearby Reference Levels at the CloseCounter Trend Trade - vinanet.vn

Aug 18, 2026

Aug 17, 2026